Retrospective analysis of treatment and prognosis for uterine leiomyosarcoma: 10-year experience of a single institute

Nursing and Health Professions

• Abdominal Hysterectomy 5%
• Adjuvant Chemotherapy 15%
• Analysis 5%
• Cancer Surgery 10%
• Chemotherapy 5%
• Combination Therapy 10%
• Diseases 30%
• Docetaxel 5%
• Gemcitabine 5%
• Leiomyosarcoma 20%
• Lymph Node Dissection 5%
• Observation 5%
• Patient 100%
• Procedures 5%
• Prognosis 25%
• Recurrent Disease 5%
• Salpingooophorectomy 5%
• Surgical Technique 5%
• Uterus Sarcoma 5%
• Woman 10%

Medicine and Dentistry

• Abdominal Hysterectomy 5%
• Adjuvant Chemotherapy 15%
• Age 5%
• Analysis 5%
• Cancer 5%
• Cancer Surgery 10%
• Combination Therapy 10%
• Diseases 30%
• Docetaxel 5%
• Experience 5%
• Gemcitabine 5%
• Leiomyosarcoma 20%
• Observation 5%
• Radiation 5%
• Recurrent Disease 5%
• Retroperitoneal Lymph Node Dissection 5%
• Salpingooophorectomy 5%
• Surgical Technique 5%
• Targeted Therapy 5%
• Therapeutic Procedure 15%
• Uterus Sarcoma 5%